It has been found, among others, that 135C variant may increase the risk of breast cancer in carriers of mutations in BRCA1 and BRCA2 genes, while no effects of 135C variant were observed on the morbidity level in women without the mutations. This evidence concerns the gene BRCA1 and breast carcinoma.